Teva Pharmaceuticals Expanding Antibiotic Plant Down Mexico, Missouri Way

---

Researched by Industrialinfo.com (Industrial Information Resources, Incorporated; Houston, Texas). Teva Pharmaceuticals Industries Limited (NASDAQ: TEVA) (Jerusalem, Israel) subsidiary, Teva Pharmaceuticals USA Incorporated (North Wales, Pennsylvania) is expanding its antibiotics manufacturing plant in Mexico, Missouri. Aided by a strong local incentive package, the company will spend up to $3 million to install the new production equipment, including new reactor vessels. (Plant 1018513)

The Mexico plant first opened in 1990 and operated under the name of Biocraft until a merger with Teva in 1996. The plant currently manufactures older generation antibiotics, including amoxicillin and penicillin. As demand waned for the plant's product lines, the company curtailed production and laid off 40 people in 2002.The new antibiotics that Teva will add to the production line are cefadroxil, cefdinir, cefaprozil, and dioxicilin. The company expects to hire an additional 12 people as a result of the expansion, which is scheduled to be complete in 2006.

Click the following link to view Industrialinfo.com's new 2004 North American Pharmaceutical-Biotech Forecast and the entire Pharmaceutical-Biotech Database.

Join Industrialinfo.com at the Pharmaceutical industry's premier forum - INTERPHEX2004 March 16-18th at the Jacob K. Javits Convention Center in New York City. Visit us at booth C2622. Click here and get your free pass to INTERPHEX2004. Just print the form provided. We look forward to seeing you at the show!